Limits...
The CacyBP/SIP protein is sumoylated in neuroblastoma NB2a cells.

Wasik U, Filipek A - Neurochem. Res. (2013)

Bottom Line: In this work we examined a post-translational modification of CacyBP/SIP which might have an effect on its function.By fractionation of NB2a cell extract we have found that, contrary to the majority of SUMO-modified proteins, sumoylated CacyBP/SIP is present in the cytoplasmic and not in the nuclear fraction.We have also established that lysine 16 is the residue which undergoes sumoylation in the CacyBP/SIP protein.

View Article: PubMed Central - PubMed

ABSTRACT
The Calcyclin binding protein and Siah-1 interacting protein (CacyBP/SIP) protein is highly expressed in mammalian brain as well as in neuroblastoma NB2a cells and pheochromocytoma PC12 cells. This protein interacts with several targets such as cytoskeletal proteins or ERK1/2 kinase and seems to be involved in many cellular processes. In this work we examined a post-translational modification of CacyBP/SIP which might have an effect on its function. Since theoretical analysis of the amino acid sequence of CacyBP/SIP indicated several lysine residues which could potentially be sumoylated we checked experimentally whether this protein might be modified by SUMO attachment. We have shown that indeed CacyBP/SIP bound the E2 SUMO ligase, Ubc9, in neuroblastoma NB2a cell extract and was sumoylated in these cells. By fractionation of NB2a cell extract we have found that, contrary to the majority of SUMO-modified proteins, sumoylated CacyBP/SIP is present in the cytoplasmic and not in the nuclear fraction. We have also established that lysine 16 is the residue which undergoes sumoylation in the CacyBP/SIP protein.

Show MeSH

Related in: MedlinePlus

Sumoylation of CacyBP/SIP in neuroblastoma NB2a cells. Western blot developed with anti-CacyBP/SIP antibody shows sumoylated CacyBP/SIP in cell extract (A) and in subcellular fractions of NB2a cells (B). In each case 80 μg of protein was applied on the gel. Panel C shows that wild type CacyBP/SIP (WT) is sumoylated in NB2a cell extract while K16R CacyBP/SIP mutant is not. Western blot images representative for 3 experiments performed are shown
© Copyright Policy - OpenAccess
Related In: Results  -  Collection


getmorefigures.php?uid=PMC3824344&req=5

Fig3: Sumoylation of CacyBP/SIP in neuroblastoma NB2a cells. Western blot developed with anti-CacyBP/SIP antibody shows sumoylated CacyBP/SIP in cell extract (A) and in subcellular fractions of NB2a cells (B). In each case 80 μg of protein was applied on the gel. Panel C shows that wild type CacyBP/SIP (WT) is sumoylated in NB2a cell extract while K16R CacyBP/SIP mutant is not. Western blot images representative for 3 experiments performed are shown

Mentions: To examine if CacyBP/SIP is sumoylated in the cell, neuroblastoma NB2a cells were transfected with plasmids encoding proteins that enhance this modification i.e., Ubc9 and SUMO as described in Materials and Methods. As it is seen in Fig. 3A an additional band recognized by anti-CacyBP/SIP antibody at the level of 75 kDa becomes visible. This band, representing EYFP-SUMO1-CacyBP/SIP-3xFLAG, is detected in cells overexpressing SUMO1-EYFP, Ubc9-FLAG and CacyBP/SIP-3xFLAG but not in cells overexpressing only CacyBP/SIP-3xFLAG. In order to establish the subcellular localization of sumoylated CacyBP/SIP, NB2a cells were subjected to fractionation into nuclear and cytoplasmic fractions. As it can be seen in Fig. 3B, the EYFP-SUMO1-CacyBP/SIP-3xFLAG band migrating at the level of 75 kDa is present in the cytoplasmic fraction and not in the nuclear one. In the nuclear fraction a band migrating at the level of 66 kDa was detected with anti-CacyBP/SIP antibody, which most probably represents CacyBP/SIP dimer [16].Fig. 3


The CacyBP/SIP protein is sumoylated in neuroblastoma NB2a cells.

Wasik U, Filipek A - Neurochem. Res. (2013)

Sumoylation of CacyBP/SIP in neuroblastoma NB2a cells. Western blot developed with anti-CacyBP/SIP antibody shows sumoylated CacyBP/SIP in cell extract (A) and in subcellular fractions of NB2a cells (B). In each case 80 μg of protein was applied on the gel. Panel C shows that wild type CacyBP/SIP (WT) is sumoylated in NB2a cell extract while K16R CacyBP/SIP mutant is not. Western blot images representative for 3 experiments performed are shown
© Copyright Policy - OpenAccess
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC3824344&req=5

Fig3: Sumoylation of CacyBP/SIP in neuroblastoma NB2a cells. Western blot developed with anti-CacyBP/SIP antibody shows sumoylated CacyBP/SIP in cell extract (A) and in subcellular fractions of NB2a cells (B). In each case 80 μg of protein was applied on the gel. Panel C shows that wild type CacyBP/SIP (WT) is sumoylated in NB2a cell extract while K16R CacyBP/SIP mutant is not. Western blot images representative for 3 experiments performed are shown
Mentions: To examine if CacyBP/SIP is sumoylated in the cell, neuroblastoma NB2a cells were transfected with plasmids encoding proteins that enhance this modification i.e., Ubc9 and SUMO as described in Materials and Methods. As it is seen in Fig. 3A an additional band recognized by anti-CacyBP/SIP antibody at the level of 75 kDa becomes visible. This band, representing EYFP-SUMO1-CacyBP/SIP-3xFLAG, is detected in cells overexpressing SUMO1-EYFP, Ubc9-FLAG and CacyBP/SIP-3xFLAG but not in cells overexpressing only CacyBP/SIP-3xFLAG. In order to establish the subcellular localization of sumoylated CacyBP/SIP, NB2a cells were subjected to fractionation into nuclear and cytoplasmic fractions. As it can be seen in Fig. 3B, the EYFP-SUMO1-CacyBP/SIP-3xFLAG band migrating at the level of 75 kDa is present in the cytoplasmic fraction and not in the nuclear one. In the nuclear fraction a band migrating at the level of 66 kDa was detected with anti-CacyBP/SIP antibody, which most probably represents CacyBP/SIP dimer [16].Fig. 3

Bottom Line: In this work we examined a post-translational modification of CacyBP/SIP which might have an effect on its function.By fractionation of NB2a cell extract we have found that, contrary to the majority of SUMO-modified proteins, sumoylated CacyBP/SIP is present in the cytoplasmic and not in the nuclear fraction.We have also established that lysine 16 is the residue which undergoes sumoylation in the CacyBP/SIP protein.

View Article: PubMed Central - PubMed

ABSTRACT
The Calcyclin binding protein and Siah-1 interacting protein (CacyBP/SIP) protein is highly expressed in mammalian brain as well as in neuroblastoma NB2a cells and pheochromocytoma PC12 cells. This protein interacts with several targets such as cytoskeletal proteins or ERK1/2 kinase and seems to be involved in many cellular processes. In this work we examined a post-translational modification of CacyBP/SIP which might have an effect on its function. Since theoretical analysis of the amino acid sequence of CacyBP/SIP indicated several lysine residues which could potentially be sumoylated we checked experimentally whether this protein might be modified by SUMO attachment. We have shown that indeed CacyBP/SIP bound the E2 SUMO ligase, Ubc9, in neuroblastoma NB2a cell extract and was sumoylated in these cells. By fractionation of NB2a cell extract we have found that, contrary to the majority of SUMO-modified proteins, sumoylated CacyBP/SIP is present in the cytoplasmic and not in the nuclear fraction. We have also established that lysine 16 is the residue which undergoes sumoylation in the CacyBP/SIP protein.

Show MeSH
Related in: MedlinePlus